Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-(acetylamino)-3,5-dideoxy-d-glycero-d-galacto-2-nonulopyranosonic Acid
2. 5-(acetylamino)-3,5-dideoxy-d-glycero-d-galacto-2-nonulosonic Acid
3. 5-(acetylamino)-3,5-dideoxy-d-glycero-d-galacto-non-2-nonulosonic Acid
4. 5-(acetylamino)-3,5-dideoxy-d-glycero-d-galacto-non-2-ulopyranosonic Acid
5. D-glycero-5-acetamido-3,5-dideoxy-d-galacto-non-2-ulo-pyranosonic Acid
6. N-acetylneuraminic Acid
7. Neu5ac
8. N-acetylneuraminate
9. Neuac
10. Acidium Aceneuramicum
11. 131-48-6
12. O-sialic Acid
13. Neuraminic Acid, N-acetyl-
14. Acide Aceneuramique
15. Chembl4280954
16. Chebi:17012
17. Nsc 111756
18. 5-acetamido-3,5-dideoxy-d-glycero-d-galacto-2-nonulosonic Acid
19. 5-n-acetylneuraminic Acid
20. 489-46-3
21. Nsc111756
22. 5-acetamido-3,5-dideoxy-d-glycero-d-galacto-non-2-ulopyranosonic Acid
23. Bmse000057
24. Epitope Id:146100
25. Schembl236448
26. Bdbm50468556
27. Akos025311078
28. C00270
29. A806270
30. F_full_00010000000000_gs_6869
31. Wurcs=2.0/1,1,0/[aad21122h-2x_2-6_5*ncc/3=o]/1/
32. 5-(acetylamino)-3,5-dideoxy-d-glycero-d-galacto-2-nonulosonicaci;galactononulosonic Acid
33. (4s,5r,6r)-5-acetamido-2,4-bis(oxidanyl)-6-[(1r,2r)-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic Acid
34. (4s,5r,6r)-5-acetamido-2,4-dihydroxy-6-[(1r,2r)-1,2,3-trihydroxypropyl]tetrahydropyran-2-carboxylic Acid
35. 6alpha-[(1r,2r)-1,2,3-trihydroxypropyl]-5beta-(acetylamino)-2,4alpha-dihydroxytetrahydro-2h-pyran-2-carboxylic Acid
| Molecular Weight | 309.27 g/mol |
|---|---|
| Molecular Formula | C11H19NO9 |
| XLogP3 | -3.5 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 309.10598118 g/mol |
| Monoisotopic Mass | 309.10598118 g/mol |
| Topological Polar Surface Area | 177 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 403 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A N-Acetyl-Neuraminic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Acetyl-Neuraminic Acid, including repackagers and relabelers. The FDA regulates N-Acetyl-Neuraminic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Acetyl-Neuraminic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Acetyl-Neuraminic Acid supplier is an individual or a company that provides N-Acetyl-Neuraminic Acid active pharmaceutical ingredient (API) or N-Acetyl-Neuraminic Acid finished formulations upon request. The N-Acetyl-Neuraminic Acid suppliers may include N-Acetyl-Neuraminic Acid API manufacturers, exporters, distributors and traders.
N-Acetyl-Neuraminic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Acetyl-Neuraminic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Acetyl-Neuraminic Acid GMP manufacturer or N-Acetyl-Neuraminic Acid GMP API supplier for your needs.
A N-Acetyl-Neuraminic Acid CoA (Certificate of Analysis) is a formal document that attests to N-Acetyl-Neuraminic Acid's compliance with N-Acetyl-Neuraminic Acid specifications and serves as a tool for batch-level quality control.
N-Acetyl-Neuraminic Acid CoA mostly includes findings from lab analyses of a specific batch. For each N-Acetyl-Neuraminic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Acetyl-Neuraminic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Acetyl-Neuraminic Acid EP), N-Acetyl-Neuraminic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Acetyl-Neuraminic Acid USP).
LOOKING FOR A SUPPLIER?
